Сравнение

Plecanatid vs. Terlipressin

Два пептида рядом — идентичность, доказательная база, правовой статус и известные нежелательные явления.

Идентичность

Категория

Исследования (прочее)

Номер CAS

467426-54-6

14636-12-5

Молекулярная масса

1682 g/mol

1227.37 g/mol

Период полувыведения

нет данных

Последовательность

нет данных

Механизм действия

Plecanatid

Plecanatide is structurally analogous to the body's own uroguanylin and, like it, activates the GC-C receptor at the gut surface, raising cGMP and fluid secretion. Its pH-dependent activity shifts the effect toward the proximal small intestine.

Terlipressin

Terlipressin is slowly converted in the body to lysine-vasopressin by cleavage of the three N-terminal glycyl residues (reservoir effect) and activates V1 receptors. The splanchnic vasoconstriction improves renal perfusion in hepatorenal syndrome.

Доказательная база

Наивысшая доказательность

РКИ на людях

Исследования

из них на людях

Зафиксированные эффекты

Открытые противоречия

Задокументированные нежелательные явления

Правовой статус

Country	Plecanatid	Terlipressin
Германия	Не одобрено	Рецептурный
США	Рецептурный	Рецептурный

Полные записи

Frequently asked questions

What is the difference between Plecanatid and Terlipressin?: Plecanatid is classified as "Исследования (прочее)", while Terlipressin is classified as "Исследования (прочее)". Plecanatid: Plecanatide is a 16-amino-acid analog of the body's own uroguanylin and a guanylate cyclase-C (GC-C) agonist. It is approved for chronic idiopathic constipation (CIC) and IBS with constipation (IBS-C). Terlipressin: Terlipressin is a 12-amino-acid vasopressin analog and prodrug of lysine-vasopressin. As a V1 receptor agonist it is vasoconstrictive and is approved for hepatorenal syndrome (FDA 2022, Terlivaz). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Plecanatid or Terlipressin?: The highest available evidence level is "РКИ на людях" for Plecanatid and "РКИ на людях" for Terlipressin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Plecanatid and Terlipressin in Germany and the United States?: Германия: Plecanatid — Не одобрено, Terlipressin — Рецептурный. США: Plecanatid — Рецептурный, Terlipressin — Рецептурный. These are factual summaries with source and review date on the individual pages.

Country

Plecanatid

Terlipressin

Германия

Не одобрено

Рецептурный

США

Рецептурный

Frequently asked questions

What is the difference between Plecanatid and Terlipressin?

Plecanatid is classified as "Исследования (прочее)", while Terlipressin is classified as "Исследования (прочее)". Plecanatid: Plecanatide is a 16-amino-acid analog of the body's own uroguanylin and a guanylate cyclase-C (GC-C) agonist. It is approved for chronic idiopathic constipation (CIC) and IBS with constipation (IBS-C). Terlipressin: Terlipressin is a 12-amino-acid vasopressin analog and prodrug of lysine-vasopressin. As a V1 receptor agonist it is vasoconstrictive and is approved for hepatorenal syndrome (FDA 2022, Terlivaz). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Plecanatid or Terlipressin?

The highest available evidence level is "РКИ на людях" for Plecanatid and "РКИ на людях" for Terlipressin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Plecanatid and Terlipressin in Germany and the United States?

Германия: Plecanatid — Не одобрено, Terlipressin — Рецептурный. США: Plecanatid — Рецептурный, Terlipressin — Рецептурный. These are factual summaries with source and review date on the individual pages.